DiabetesBio

By: American Diabetes Association
  • Summary

  • DiabetesBio co-hosts Darleen Sandoval (University of Colorado), Kirk Habegger (University of Alabama-Birmingham), and Kevin Williams (UT Southwestern) interview authors of editor-selected biomedical research articles published in the journal Diabetes, the American Diabetes Association's flagship research publication.
    2023
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Grøndahl on glucagon clearance decrease in kidney disease despite preservation in liver cirrhosis, Barra and Russ on cryopreservation of stem cell–derived β-like cells, Sunilkumar and Dennis on targeting REDD1 to combat diabetes complications, & more!
    Oct 10 2024

    Welcome to the October 2024 episode of DiabetesBio—the American Diabetes Association’s podcast for its flagship research publication, Diabetes. In this episode of DiabetesBio, Drs. Kirk Habegger, Darleen Sandoval, and Kevin Williams discuss the latest and greatest content in the October 2024 issue of Diabetes and interview a Pathway to Stop Diabetes award winner.

    4:05 This month’s episode begins with a special offer from the ADA for new and renewing members: a 15% discount on a 1- or 2-year membership. Go to professional.diabetes.org/membership, create your account, fill out the application, and use the discount code ‘FALL24’ at checkout. Act fast because this offer expires November 30, 2024!

    5:15 Darleen and Kirk speak with Dr. Magnus Grøndahl, faculty of Health and Medical Sciences and doctor of medicine at University of Copenhagen, about his paper, “Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis.” This article is available for free at doi.org/10.2337/db24-0305.

    19:05 Our hosts discuss a featured article entitled “Cryopreservation of Stem Cell–Derived β-Like Cells Enriches for Insulin-Producing Cells With Improved Function.” They’re joined by the study’s lead author, Dr. Jessie Barra, and corresponding author—as well as Barra’s mentor—Dr. Holger Russ. This study is available at doi.org/10.2337/db24-0346.

    35:00 Finally, just in time for National Vision Awareness Month, a Sweet Talk segment first: a discussion on the important topic of diabetic retinopathy. Dr. Siddharth Sunilkumar and Dr. Michael Dennis discuss their Perspectives article, “REDD1 Is a Promising Therapeutic Target to Combat the Development of Diabetes Complications: A Report on Research Supported by Pathway to Stop Diabetes,” funded by the ADA Pathway to Stop Diabetes Initiator Award, which was given to Dr. Dennis in 2014. This article is freely accessible at doi.org/10.2337/dbi24-0013.

    To learn more about Diabetes and DiabetesBio, please visit diabetesjournals.org/diabetes. Thank you for listening, and don’t forget to smash that “follow” button!

    Show more Show less
    51 mins
  • Jose Ortiz and Teresa Ku on trefoil factor 2 expression by pancreatic acinar cells, Adrian Vella on the effect of diabetes-associated variation in TCF7L2 on islet function, Matthew Webber on being a Pathway to Stop Diabetes awardee, and more!
    Sep 4 2024

    Welcome to the September 2024 episode of DiabetesBio—the American Diabetes Association’s podcast for its flagship research publication, Diabetes. In this episode of DiabetesBio, Drs. Kirk Habegger, Darleen Sandoval, and Kevin Williams discuss the latest and greatest content in the September 2024 issue of Diabetes and interview a Pathway to Stop Diabetes award winner.

    4:20: Darleen and Kirk are joined by Jose A. Ortiz and Hsun Teresa Ku, first and last authors of “Trefoil Factor 2 Expressed by the Murine Pancreatic Acinar Cells Is Required for the Development of Islets and for β-Cell Function During Aging.” This article is an editor-selected feature article and is freely accessible at https://doi.org/10.2337/db23-0490.

    25:07: Kirk and Darleen talk to Adrian Vella, last author of “The Longitudinal Effect of Diabetes-Associated Variation in TCF7L2 on Islet Function in Humans.” This article is also an editor-selected feature article and is freely accessible at https://doi.org/10.2337/db24-0192.

    50:21: In this month’s Sweet Talk segment, Kevin chats with Matthew J. Webber, a 2019 Pathway to Stop Diabetes Accelerator Award winner, about his research on materials that can sense and respond to changing glucose.

    To learn more about Diabetes and DiabetesBio, please visit diabetesjournals.org/diabetes. Thank you for listening, and don’t forget to smash that “follow” button!

    Show more Show less
    1 hr and 2 mins
  • Scientific Sessions Reviewed by ADA Podcast Co-Hosts! In this special episode, the co-hosts of DiabetesBio, Diabetes Care “On Air,” Diabetes Core Update, and Diabetes Day by Day discuss highlights from the ADA’s 2024 Scientific Sessions
    Aug 16 2024

    Welcome to a very special episode of DiabetesBio—the American Diabetes Association’s podcast for its flagship research publication, Diabetes. While this podcast usually focuses on the research published in Diabetes, this unique episode focuses on the incredible scholarly content of the 84th Scientific Sessions, which took place 2124 June in Orlando, FL. Alice Cheng, MD, FRCPC, co-host of Diabetes CareOn Air,” acted as emcee for a panel discussion with Michael Rickels, MD, MS, her co-host on Diabetes Care “On Air”; Kirk Habegger, PhD, Darleen Sandoval, PhD, and Kevin Williams, PhD, the co-hosts of DiabetesBio; and Neil Skolnik, MD, co-host of Diabetes Core Update and Diabetes Day by Day. This episode is being released on three of our professional podcasts: Diabetes Care “On Air,” DiabetesBio, and Diabetes Core Update. This special episode is supported by an independent educational grant from Bayer.

    This wide-ranging discussion begins with introductions and brief descriptions of the various podcasts, and then the panelists highlight their favorite sessions and events from the 84th Scientific Sessions—the new, high-impact research presented at the meeting, implications for future research, and clinical considerations and take-aways—across the “bench-to-bedside” spectrum of biomedical research, clinical research, and treatment advances. (Please note that anyone who registered for the event can still access the recorded content at ada2024.org until August 26.)

    Correction:
    •Dr. Carmella Evans-Molina is from the Indiana University School of Medicine
    •Dr. Lou Philipson is from the University of Chicago

    To learn more about Diabetes and DiabetesBio, please visit diabetesjournals.org/diabetes. Thank you for listening, and don’t forget to smash that “follow” button!

    Show more Show less
    55 mins

What listeners say about DiabetesBio

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.